normal human immunoglobulin

The drug is used for replacement therapy in primary and secondary immunodeficiencies, as well as for the treatment of severe bacterial and viral infections. It is also used for immunomodulation in conditions such as Guillain-Barré syndrome, Kawasaki disease, primary immune thrombocytopenia, and certain autoimmune diseases.

Form: solution for infusion

ATC: J06BA02

Manufacturer: Biopharma Plazma LLC (manufacturing, primary and secondary packaging, quality control, batch release)

The drug is used for replacement immunotherapy in primary and secondary immunodeficiency states (e.g., in congenital agammaglobulinemia or severe infections). It is also used in certain autoimmune diseases (e.g., Guillain-Barré syndrome, idiopathic thrombocytopenic purpura) and as part of complex therapy for adults with severe pneumonia caused by COVID-19.

Form: solution for infusion

ATC: J06BA02

Manufacturer: Biopharma Plazma LLC (manufacturing, primary and secondary packaging, quality control, batch release)

The drug is used for replacement therapy in adults, children, and adolescents with primary immunodeficiency syndrome, hypogammaglobulinemia, as well as for certain infections in the context of chronic lymphocytic leukemia, multiple myeloma, or after stem cell transplantation.

Form: solution for injection

ATC: J06BA01

Manufacturer: Octapharma AB (manufacturer responsible for manufacturing in bulk, primary packaging, batch release)

The drug is used to treat allergic diseases such as chronic urticaria, atopic dermatitis, eczema, asthmatic bronchitis, and pollinosis. It is also applied in cases of recurrent Quincke's edema (except for hereditary cases). Treatment is carried out during periods of remission of allergic processes.

Form: lyophilisate for solution for injection

ATC: J06BB30

Manufacturer: JSC "BIOLIK"

The drug is used for the prevention of hepatitis A and measles, as well as for the treatment of hypo- and agammaglobulinemia. It is also used to boost the body's protective forces during recovery from acute infections with a prolonged course.

Form: solution for injection

ATC: J06BA01

Manufacturer: JSC "BIOLIK"

The drug is used for replacement therapy in primary and secondary immunodeficiencies (when the body does not produce enough antibodies). It is also used for immunomodulation in conditions such as primary immune thrombocytopenia, Guillain-Barré syndrome, Kawasaki disease, chronic inflammatory demyelinating polyradiculoneuropathy, and multifocal motor neuropathy.

Form: solution for infusion

ATC: J06BA02

Manufacturer: Baxter Belgium Manufacturing SA (manufacturing, primary and secondary packaging, GLP quality control, batch release)

It is used as replacement therapy for adults and children with primary immunodeficiency syndrome (with decreased antibody production), as well as for secondary immunodeficiencies accompanied by severe or recurrent infections.

Form: solution for injection

ATC: J06BA01

Manufacturer: Octapharma AB (manufacturer responsible for bulk manufacturing, primary packaging, quality control, batch release)